Lab-on-chip assay of tumour markers and human papilloma virus for cervical cancer detection at the point-of-care

Cervical cancer affects over half a million people worldwide each year, the majority of whom are in resource-limited settings where cytology screening is not available. As persistent human papilloma virus (HPV) infections are a key causative factor, detection of HPV strains now complements cytology...

Descripción completa

Detalles Bibliográficos
Autores principales: Wormald, Benjamin W., Moser, Nicolas, deSouza, Nandita M., Mantikas, Katerina-Theresa, Malpartida-Cardenas, Kenny, Pennisi, Ivana, Ind, Thomas E. J., Vroobel, Katherine, Kalofonou, Melpomeni, Rodriguez-Manzano, Jesus, Georgiou, Pantelis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128326/
https://www.ncbi.nlm.nih.gov/pubmed/35610285
http://dx.doi.org/10.1038/s41598-022-12557-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128326/
https://www.ncbi.nlm.nih.gov/pubmed/35610285
http://dx.doi.org/10.1038/s41598-022-12557-y

Ejemplares similares